Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BI 671800 efficacy and safety in symptomatic asthma
NCT01090024Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Mar 2010
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BI-671800 in asthma, sponsored by Boehringer Ingelheim. Started Mar 2010; status: completed.
02
Drugs
BI-671800
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01090024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01090024.